115 related articles for article (PubMed ID: 2700994)
1. Molecular features of the H-2 class I and Qa antigens expressed on Gross virus induced AKR leukaemias.
Festenstein H
J Immunogenet; 1989; 16(4-5):329-33. PubMed ID: 2700994
[No Abstract] [Full Text] [Related]
2. The generation and specificity of cytotoxic T cells raised against syngeneic tumor cells bearing AKR/Gross murine leukemia virus antigens.
Green WR; Nowinski RC; Henney CS
J Exp Med; 1979 Jul; 150(1):51-66. PubMed ID: 109575
[TBL] [Abstract][Full Text] [Related]
3. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
Green WR
J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
[TBL] [Abstract][Full Text] [Related]
4. The expression of an "alloantigen"-like molecule is a general phenomenon in AKR leukaemias.
Labeta M; Fernandez N; Festenstein H
Transplant Proc; 1989 Feb; 21(1 Pt 1):578. PubMed ID: 2705236
[No Abstract] [Full Text] [Related]
5. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
Green WR
J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
[TBL] [Abstract][Full Text] [Related]
6. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. I. Isolation of a selectively resistant variant tumor subclone.
Green WR
Eur J Immunol; 1983 Nov; 13(11):863-70. PubMed ID: 6196206
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of nonresponsiveness to AKR/Gross leukemia virus in AKR.H-2b:Fv-1b mice. An analysis of precursor cytotoxic T lymphocyte frequencies in young versus moderately aged mice.
Wegmann KW; McMaster JS; Green WR
J Immunol; 1991 Apr; 146(7):2469-77. PubMed ID: 2005406
[TBL] [Abstract][Full Text] [Related]
8. Resistance to cell-mediated cytotoxicity is correlated with reduction of H-2K gene products in AKR leukemia.
Schmidt W; Festenstein H
Immunogenetics; 1982; 16(3):257-64. PubMed ID: 6982849
[TBL] [Abstract][Full Text] [Related]
9. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
Green WR
J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
[TBL] [Abstract][Full Text] [Related]
10. Clonal heterogeneity of anti-AKR/gross leukemia virus cytotoxic T lymphocytes. Evidence for two distinct antigen systems.
Azuma H; Phillips JD; Green WR
J Immunol; 1987 Oct; 139(7):2464-73. PubMed ID: 2821116
[TBL] [Abstract][Full Text] [Related]
11. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. II. Altered gp70 display and production of noninfectious virus particles by an insusceptible variant tumor.
Green WR; Brown MA
Eur J Immunol; 1983 Nov; 13(11):871-7. PubMed ID: 6196207
[TBL] [Abstract][Full Text] [Related]
12. Age-dependent leukemia produced in thymectomized AKR mice by antiserum to leukemic cells.
Kohn RR; Sciotto CG; Hensse S
Exp Gerontol; 1978; 13(3-4):181-7. PubMed ID: 689114
[No Abstract] [Full Text] [Related]
13. Resistance to cellular immune response in AKR leukemias.
Schäfer A; Schmidt W
Eur J Immunol; 1986 Jul; 16(7):753-9. PubMed ID: 2424771
[TBL] [Abstract][Full Text] [Related]
14. H-2-restricted cytolytic T lymphocytes specific for a subclass of AKR endogenous leukemia virus-induced tumors: correlation of tumor cell susceptibility with expression of the gross cell surface antigen.
Green WR
J Immunol; 1980 Dec; 125(6):2584-90. PubMed ID: 6159413
[No Abstract] [Full Text] [Related]
15. H-2-specific antibodies induced by injection of syngeneic leukemia cells.
Schmidt W
Immunogenetics; 1987; 25(4):215-21. PubMed ID: 3570375
[TBL] [Abstract][Full Text] [Related]
16. Expression of antigens coded in murine leukemia viruses on thymocytes of allogeneic donor origin in AKR mice following syngeneic or allogeneic bone marrow transplantation.
Wustrow TP; Good RA
Cancer Res; 1985 Dec; 45(12 Pt 1):6428-35. PubMed ID: 2998600
[TBL] [Abstract][Full Text] [Related]
17. COMPARISON OF TUMOUR ANTIGENS IN AKR AND GROSS VIRUS (PASSAGE A)-INDUCED LEUKAEMIAS.
WAHREN B
Nature; 1965 Jan; 205():409-10. PubMed ID: 14243441
[No Abstract] [Full Text] [Related]
18. Organization of the AKR Qa region: structure of a divergent class I sequence, Q5k.
Weiss EH; Bevec D; Messer G; Schwemmle S; Grosshaus C; Steinmetz M; Schmidt W
J Immunogenet; 1989; 16(4-5):283-90. PubMed ID: 2639903
[TBL] [Abstract][Full Text] [Related]
19. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors.
Manjunath R; Graziano RF; Green WR
J Immunol; 1986 Mar; 136(6):2271-9. PubMed ID: 3005407
[TBL] [Abstract][Full Text] [Related]
20. Variation in MHC antigenic profiles of tumor cells and its biological effects.
Festenstein H; Schmidt W
Immunol Rev; 1981; 60():85-127. PubMed ID: 6171505
[No Abstract] [Full Text] [Related]
[Next] [New Search]
